Welcome to the seventh issue of Health Headlines, a newsletter created by lawyers in our Healthcare practice.
Iowa Governor Kim Reynolds signed Senate File 383 into law, placing new restrictions on pharmacy benefit...more
7/1/2025
/ Children's Health Insurance Program (CHIP) ,
Constitutional Challenges ,
Data Breach ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Healthcare ,
Medicaid ,
Medicare ,
Medicare Advantage ,
New Legislation ,
OIG ,
Pharmacies ,
Pharmacy Benefit Manager (PBM) ,
Prescription Drugs ,
Proposed Legislation ,
State and Local Government
Welcome to the third issue of Health Headlines, a newsletter created by lawyers in our Healthcare practice....more
3/30/2025
/ Affordable Care Act ,
Annual Reports ,
Caremark claim ,
Centers for Medicare & Medicaid Services (CMS) ,
Criminal Prosecution ,
CVS ,
Drug Pricing ,
Executive Orders ,
Federal Trade Commission (FTC) ,
Healthcare ,
Healthcare Fraud ,
Medicaid ,
Medicare ,
Pharmaceutical Industry ,
Price Transparency ,
Proposed Rules ,
Trump Administration
Last week, we reported Celltrion’s U.S. launch of STEQEYMA® (ustekinumab-stba), a biosimilar of Janssen’s STELARA® (ustekinumab). According to Celltrion, STEQEYMA® is being sold at a wholesale acquisition cost (WAC) list...more
On March 1, Eli Lilly was the first to announce U.S. list price reductions of 70% for its most commonly prescribed insulins and an expansion of its Insulin Value Program that caps patient out-of-pocket costs at $35 or less...more